Regarding Pharmacology, Part 3A

Journal of Nuclear Medicine Technology（2019）

引用 1|浏览3

暂无评分

摘要

TO THE EDITOR: I read “Pharmacology, Part 3A” in the December 2018 issue of the Journal of Nuclear Medicine Technology by Geoffrey M. Currie ([1][1]). I am concerned about one aspect of the discussion, specifically that of cholecystokinin, or its analog, sincalide (Kinevac; Bracco Diagnostics,

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要